Literature DB >> 25166350

Performance of the NINDS-CSN 5-minute protocol in a national population-based sample.

Richard E Kennedy1, Virginia G Wadley1, Leslie A McClure2, Abraham J Letter3, Frederick W Unverzagt4, Michael Crowe5, David Nyenhius6, Brendan J Kelley7, Bhumika Kana1, Janice Marceaux5, Manjula Kurella Tamura8, Virginia Howard9, George Howard1.   

Abstract

In 2006, the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network (NINDS-CSN) Vascular Cognitive Impairment Harmonization Standards recommended a 5-Minute Protocol as a brief screening instrument for vascular cognitive impairment (VCI). We report demographically adjusted norms for the 5-Minute Protocol and its relation to other measures of cognitive function and cerebrovascular risk factors. We performed a cross-sectional analysis of 7199 stroke-free adults in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study on the NINDS-CSN 5-Minute Protocol score. Total scores on the 5-Minute Protocol were inversely correlated with age and positively correlated with years of education, and performance on the Six-Item Screener, Word List Learning, and Animal Fluency (all p-values <.001). Higher cerebrovascular risk on the Framingham Stroke Risk Profile (FSRP) was associated with lower total 5-Minute Protocol scores (p <.001). The 5-Minute Protocol also differentiated between participants with and without confirmed stroke and with and without stroke symptom histories (p <.001). The NINDS-CSN 5-Minute Protocol is a brief, easily administered screening measure that is sensitive to cerebrovascular risk and offers a valid method of screening for cognitive impairment in populations at risk for VCI.

Entities:  

Mesh:

Year:  2014        PMID: 25166350      PMCID: PMC4452126          DOI: 10.1017/S1355617714000733

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  35 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  Montreal Cognitive Assessment: influence of sociodemographic and health variables.

Authors:  Sandra Freitas; Mário R Simões; Lara Alves; Isabel Santana
Journal:  Arch Clin Neuropsychol       Date:  2012-01-24       Impact factor: 2.813

3.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

4.  Incident cognitive impairment is elevated in the stroke belt: the REGARDS study.

Authors:  Virginia G Wadley; Frederick W Unverzagt; Lisa C McGuire; Claudia S Moy; Rodney Go; Brett Kissela; Leslie A McClure; Michael Crowe; Virginia J Howard; George Howard
Journal:  Ann Neurol       Date:  2011-05-26       Impact factor: 10.422

5.  Adherence to a Mediterranean diet and risk of incident cognitive impairment.

Authors:  Georgios Tsivgoulis; Suzanne Judd; Abraham J Letter; Andrei V Alexandrov; George Howard; Fadi Nahab; Frederick W Unverzagt; Claudia Moy; Virginia J Howard; Brett Kissela; Virginia G Wadley
Journal:  Neurology       Date:  2013-04-30       Impact factor: 9.910

6.  Disparities in stroke incidence contributing to disparities in stroke mortality.

Authors:  Virginia J Howard; Dawn O Kleindorfer; Suzanne E Judd; Leslie A McClure; Monika M Safford; J David Rhodes; Mary Cushman; Claudia S Moy; Elsayed Z Soliman; Brett M Kissela; George Howard
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

7.  Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination.

Authors:  W J Jones; L S Williams; J F Meschia
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

8.  Association of higher diastolic blood pressure levels with cognitive impairment.

Authors:  G Tsivgoulis; A V Alexandrov; V G Wadley; F W Unverzagt; R C P Go; C S Moy; B Kissela; G Howard
Journal:  Neurology       Date:  2009-08-25       Impact factor: 9.910

9.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

10.  Reliability of the questionnaire for verifying stroke-free status.

Authors:  James F Meschia; Marc A Lojacono; Mary J Miller; Thomas G Brott; Elizabeth J Atkinson; Peter C O'Brien
Journal:  Cerebrovasc Dis       Date:  2003-12-29       Impact factor: 2.762

View more
  6 in total

1.  PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).

Authors:  Matthew T Mefford; Robert S Rosenson; Mary Cushman; Michael E Farkouh; Leslie A McClure; Virginia G Wadley; Marguerite R Irvin; Vera Bittner; Monika M Safford; Ransi Somaratne; Keri L Monda; Paul Muntner; Emily B Levitan
Journal:  Circulation       Date:  2017-11-16       Impact factor: 29.690

2.  The relationship of longitudinal cognitive change to self-reported IADL in a general population.

Authors:  Jesse S Passler; Richard E Kennedy; Olivio J Clay; Michael Crowe; Virginia J Howard; Mary Cushman; Frederick W Unverzagt; Virginia G Wadley
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2019-03-27

3.  Baseline Cognitive Impairment in Patients With Asymptomatic Carotid Stenosis in the CREST-2 Trial.

Authors:  Ronald M Lazar; Virginia G Wadley; Terina Myers; Michael R Jones; Donald V Heck; Wayne M Clark; Randolph S Marshall; Virginia J Howard; Jenifer H Voeks; Jennifer J Manly; Claudia S Moy; Seemant Chaturvedi; James F Meschia; Brajesh K Lal; Thomas G Brott; George Howard
Journal:  Stroke       Date:  2021-08-26       Impact factor: 7.914

4.  Trajectory of Cognitive Decline After Sepsis.

Authors:  Henry E Wang; Mohammed M Kabeto; Marquita Gray; Virginia G Wadley; Paul Muntner; Suzanne E Judd; Monika M Safford; Jordan Kempker; Deborah A Levine
Journal:  Crit Care Med       Date:  2021-07-01       Impact factor: 9.296

5.  Rapid Screening for Cognitive Impairment in Parkinson's Disease: A Pilot Study.

Authors:  YanHong Dong; Way Inn Koay; Leonard Leong Litt Yeo; Christopher Li-Hsian Chen; Jing Xu; Raymond Chee Seong Seet; Erle Chuen Hian Lim
Journal:  Parkinsons Dis       Date:  2015-12-02

6.  A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan.

Authors:  Kazuo Washida; Erika Kitajima; Tomotaka Tanaka; Shuhei Ikeda; Tetsuya Chiba; Kotaro Noda; Takeshi Yoshimoto; Kazuki Fukuma; Satoshi Saito; Masafumi Ihara
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.